New stock first day | Meikang Pharmaceutical-B (02335.HK) first listed. Opening with a high increase of 86.92% in the morning session. Core product MT1013 is currently in Phase III clinical stage.

According to the app of Wisdom Finance, Maker Medicine-B (02335.HK) has been listed for the first time, with an announced pricing of 18.2 Hong Kong dollars per share. A total of 58.0544 million shares were issued, with 200 shares per lot, yielding a net amount of approximately 1.067 billion Hong Kong dollars. As of the time of writing, the stock has surged by 86.92% to 34.02 Hong Kong dollars, with a trading volume of 217 million Hong Kong dollars.